Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the languages menu
  5. Go to the help menu
  6. Go to the modules
  7. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. Canadian Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Media Room

Contact us

Sanofi Canada

2905 Place Louis-R.-Renaud
Laval, Quebec, H7V 0A3

Media inquiries

514-856-3860
Toll-free: 1-877-904-2667

Catherine Cunningham

Manager, Corporate and
Brand Communications
514-956-6120

General inquiries

514-956-6200
1-800-363-6364

Press Releases

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011

2010200920082007

2009 Archives

Dec 21, 2009

-- Combination Strengthens sanofi-aventis' Strategy to Accelerate Growth Through Innovation, Geographic Expansion and External Growth -- Chattem Provides Strong Platform for Conversion of some of...

More
Nov 30, 2009

Sanofi-aventis Canada has announced a licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic...

More
Nov 30, 2009

- First New Anti-Arrhythmic Drug to be Approved in the European Union in the Last 10 Years PARIS, Nov. 30 /CNW/ - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the European...

More
Oct 20, 2009

To view this Social Media Release, please enter the following address in your web browser....

More
Oct 19, 2009

Health Canada has approved the ClikSTAR reusable insulin pen for use with Lantus, giving...

More
Oct 8, 2009

Sanofi-aventis Canada welcomes the Quebec Biopharmaceutical Strategy and sees a strong link with its new corporate strategy. "One of the goals of sanofi-aventis is...

More
Sep 16, 2009

New executive to drive fundamental shift in business model and corporate culture To access a multimedia version of this release, please visit:...

More
Aug 12, 2009
First new treatment option in over 20 years for condition affecting 250,000 Canadians
May 27, 2009
Survey Suggests Balance Must Be struck Between Managing Costs and Employee Productivity
May 25, 2009
Survey shows most Canadians unaware of atrial fibrillation; a heart condition with serious health consequences
Apr 29, 2009
In order to facilitate an understanding of our operational performance, we comment on our adjusted income statement excluding selected items, a non-GAAP financial measure.
Feb 16, 2009
Apidra™ offers safe and effective glucose control when injected before or after meals Apidra™ SoloSTAR® pre-filled insulin pen complements company's lateste insulin
Feb 12, 2009
Multaq® (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation
 

Corporate information

CORPORATE INFORMATION